Chromocell Therapeutics (CHRO) Q4 2024 Earnings

13NovConfirmed
Q1 1
Q2 2024
Q3 2024
Q4 2024
-2.9
-2.01
-1.12
-0.23

Details

Expected EPS
-0.23
Actual EPS
N/A
Surprise EPS
0.23
Surprise Percent
+100%

Description

Chromocell Therapeutics (CHRO) will report earnings of for Q4 2024 on November 13, 2024.

0 Comments

Share your thoughts